SEC Form 4 · accession 0001104659-15-078363
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Galakatos
Director
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 9, 2015 | S | 1,000 | $60.00 | D | 11,684 | D | |
| Common StockF3 | Nov 9, 2015 | S | 500 | $60.00 | D | 6,945 | I | See Footnote |
| Common StockF4 | Nov 10, 2015 | S | 1,000 | $58.69 | D | 10,684 | D | |
| Common StockF5,F3 | Nov 10, 2015 | S | 500 | $58.69 | D | 6,445 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2015. The amount of securities beneficially owned following these sales also gives effect to the Reporting Person's prior sale of 500 shares of Common Stock, as reported on the Form 4 filed by Clarus Lifesciences II, L.P. on June 11, 2014.
- F2The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by AAG Peakham LLC on September 10, 2015.
- F3Shares are held by AAG Peakham LLC of which the Reporting Person is a manager.
- F4These shares were disposed of in multiple transactions on November 10, 2015 at actual sales prices ranging from $58.50 to $58.82 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5These shares were disposed of in multiple transactions on November 10, 2015 at actual sales prices ranging from $58.50 to $58.82 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.